Gleaning insight from the PISA trials

Philip James Tozer¹

Affiliations

PMID: 35709815
DOI: 10.1016/S2468-1253(22)00162-5

Comment

Gleaning insight from the PISA trials

Philip James Tozer. Lancet Gastroenterol Hepatol. 2022 Jul.

. 2022 Jul;7(7):587-588.

doi: 10.1016/S2468-1253(22)00162-5.

Author

Philip James Tozer¹

Affiliation

¹ Robin Phillips Fistula Research Unit, St Mark's Hospital and Academic Institute, London, HA1 3UJ, UK. Electronic address: philtozer@nhs.net.

PMID: 35709815
DOI: 10.1016/S2468-1253(22)00162-5

No abstract available

PubMed Disclaimer

Conflict of interest statement

I have received speaker's fees from Ferring and Takeda; I have taken part in advisory boards for Takeda; and I am a member of the INSPIRE registry steering group.

Comment on

Treatment of Perianal Fistulas in Crohn's Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial.
Wasmann KA, de Groof EJ, Stellingwerf ME, D'Haens GR, Ponsioen CY, Gecse KB, Dijkgraaf MGW, Gerhards MF, Jansen JM, Pronk A, van Tuyl SAC, Zimmerman DDE, Bruin KF, Spinelli A, Danese S, van der Bilt JDW, Mundt MW, Bemelman WA, Buskens CJ. Wasmann KA, et al. J Crohns Colitis. 2020 Sep 7;14(8):1049-1056. doi: 10.1093/ecco-jcc/jjaa004. J Crohns Colitis. 2020. PMID: 31919501 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Gleaning insight from the PISA trials

Affiliation

Gleaning insight from the PISA trials

Author

Affiliation

Conflict of interest statement

Comment on

Publication types

LinkOut - more resources

Full Text Sources